Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00476281
Status:
COMPLETED
Last Update Posted:
2020-04-28
First Post:
2007-05-18
Brief Title:
Nutritional Metabolic and Respiratory Status in Cystic Fibrosis
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
Multicenter Prospective Study of Abnormalies Tolerance Glucose by the Continuous Measurement of Glucose of Nutritional Status and Breathing in the Patient With Cystic Fibrosis
Status:
COMPLETED
Status Verified Date:
2020-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Diabetes is a important complication of cystic fibrosis CF The improved life expectancy of patients with cystic fibrosis as a result of advances in medical therapy has resulted in an increasing prevalence of cystic fibrosis-related diabetes CFRD CFRD is associated with accelerated pulmonary decline and increased mortality Pulmonary effects are seen some years before the diagnosis of CFRD implying that impaired glucose tolerance may be very early detrimental Insulin treatment is clearly indicated in patients with CFRD to control symptoms and reduce complications However at the state of impaired glucose tolerance or fasting hyperglycaemia current screening methods are not suitable for the early management of hyperglycaemiaThe recent introduction of the continuous glucose monitoring system CGMS which provides a continuous glucose profile has revealed to be clinically relevant in the investigation of glucose excursions over a long period This device widely use in diabetic non cystic fibrosis patients has been validated in non diabetic cystic fibrosis subjects Previous studies of continuous glucose monitoring have been realized in CF patients with normal glucose tolerance and diabetes and compared with non CF controlThe aim of our study is to evaluate the glucose profile with continuous glucose monitoring the nutritional and respiratory status in cystic fibrosis subjects according to their glucose tolerance
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None